Date published: 2025-10-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

APC4 Inhibitors

APC4 inhibitors belong to a class of chemical compounds designed to target and modulate the activity of the Anaphase-Promoting Complex subunit 4 (APC4). The APC4 protein is a crucial component of the APC, which is a large E3 ubiquitin ligase complex responsible for regulating cell cycle progression by ensuring the timely degradation of specific proteins. Within this complex, APC4 serves as a scaffold protein, aiding in the proper assembly and function of the entire APC. Inhibition of APC4 is aimed at disrupting the intricate balance maintained by the APC during the cell cycle, particularly during the transition from metaphase to anaphase. By selectively impeding the activity of APC4, these inhibitors interfere with the ubiquitin-mediated proteolysis of target proteins, thereby influencing the precise orchestration of events that govern cell division.

APC4 inhibitors are designed with a high degree of specificity to interact with the active site or regulatory regions of APC4. These compounds often possess distinct chemical moieties that facilitate binding to the target protein, disrupting its function in a reversible or irreversible manner. Through this targeted interference, APC4 inhibitors have the potential to serve as valuable tools for studying the fundamental mechanisms governing cell cycle regulation. Researchers leverage these inhibitors in laboratory settings to elucidate the intricacies of cell division processes, allowing for a deeper understanding of the molecular events that underlie normal and aberrant cell cycle progression. This insight into the intricacies of APC4 function may pave the way for the development of novel strategies for manipulating cellular processes and holds promise for furthering our understanding of fundamental aspects of cell biology.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Bortezomib inhibits the 26S proteasome, disrupting degradation of cell cycle regulatory proteins and indirectly affecting APC/C function.

Carfilzomib

868540-17-4sc-396755
5 mg
$40.00
(0)

Carfilzomib is a selective proteasome inhibitor, leading to the accumulation of polyubiquitinated proteins and possibly affecting APC/C activities.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

MG-132 inhibits the proteasome, leading to increased levels of APC/C substrates and altered cell cycle progression.

Apigenin

520-36-5sc-3529
sc-3529A
sc-3529B
sc-3529C
sc-3529D
sc-3529E
sc-3529F
5 mg
100 mg
1 g
5 g
25 g
100 g
1 kg
$32.00
$210.00
$720.00
$1128.00
$2302.00
$3066.00
$5106.00
22
(1)

Apigenin has been shown to inhibit the cell cycle at the G2/M phase, which may influence APC/C regulation indirectly.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$150.00
$349.00
15
(1)

ZM447439 is an Aurora kinase inhibitor, which can affect the phosphorylation state of cell cycle proteins and thus, the activity of APC/C.

MLN8237

1028486-01-2sc-394162
5 mg
$220.00
(0)

Alisertib is an Aurora kinase A inhibitor, potentially affecting the phosphorylation and function of APC/C substrates.

MLN 4924

905579-51-3sc-484814
1 mg
$280.00
1
(0)

MLN4924 inhibits NEDD8 activating enzyme, necessary for APC/C activation, thus indirectly affecting ANAPC4 activity.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$165.00
$575.00
60
(2)

Lactacystin is a proteasome inhibitor that can prevent the degradation of cell cycle regulatory proteins, indirectly influencing APC/C.

Tozasertib

639089-54-6sc-358750
sc-358750A
25 mg
50 mg
$61.00
$85.00
4
(1)

Tozasertib (VX-680) is an inhibitor of Aurora kinases, potentially modulating the phosphorylation state of APC/C components.

BI 2536

755038-02-9sc-364431
sc-364431A
5 mg
50 mg
$148.00
$515.00
8
(1)

BI 2536 is a Plk1 inhibitor, and by inhibiting Plk1, it can influence the activation of APC/C during mitosis.